Medical equipment maker
Stereotaxis Inc.
(
STXS
) reported encouraging results from its recently completed first 50
clinical procedures performed using its new Niobe ES system for
treating patients with complex cardiac arrhythmias (a disorder of
the heart rhythm). The majority of these procedures were performed
to treat atrial fibrillation, the most prevalent form of cardiac
arrhythmia.
Results from these procedures, performed in Europe, showed that
average time for completion of mapping and ablation for the initial
atrial fibrillation patients was 69 minutes.
The Niobe ES system is a part of the company's Epoch platform,
which is designed for the electrophysiology ("EP") labs. Introduced
in April 2011, Epoch is a comprehensive solution for EP labs and is
geared to improve efficiency of cardiac procedures and increase
workflow by enabling physicians to control procedures remotely.
The Epoch platform integrates the benefits of remote magnetic
catheter control, the efficiency of remote robotic device
manipulation and the Vdrive mechanical robotic platform, allowing
highly sophisticated procedural data integration and transmission.
The Epoch solution is expected to considerably cut procedure time
for all types of robotic-assisted EP procedures including atrial
fibrillation ablation procedures.
Stereotaxis commenced initial shipment of the Epoch platform in
December 2011. The shipments include six system upgrade to the
Epoch platform from the company's Niobe II magnetic navigation
system for clients across the U.S. and Europe. Based on the
positive outcome of the initial clinical procedures, Stereotaxis
plans to install 12 additional system upgrades to Niobe ES over the
next few months.
Missouri-based Stereotaxis develops and markets advanced
cardiology instrument control system for use in cardiac
catheterization labs for the treatment of coronary artery disease
and arrhythmias.
Stereotaxis offers the Niobe Magnetic Navigation System, which
allows physicians to perform complex interventional procedures.
Moreover, its Odyssey Enterprise Solution integrates and records
all lab data allowing physicians to focus on the patient for
optimal procedure efficiency. The company's competitors include
Boston Scientific
(
BSX
) and
Edwards Lifesciences
(
EW
).
BOSTON SCIENTIF (
BSX
): Free Stock Analysis Report
EDWARDS LIFESCI (
EW
): Free Stock Analysis Report
STEREOTAXIS INC (
STXS
): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment
Research